# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1837581 | B | Inhibition of human CHED in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
2. | ALA1908458 | B | Binding constant for CDC2L5 kinase domain | 72 | single protein format | Scientific Literature | |||
3. | ALA1944422 | B | Inhibition of human CHED in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
4. | ALA1174102 | B | Inhibition of CDC2L5 at 10 uM | 2 | single protein format | Scientific Literature | |||
5. | ALA2209339 | B | Inhibition of CDC2L5 assessed as residual activity at 10 uM relative to control | 1 | single protein format | Scientific Literature | |||
6. | ALA3991653 | B | Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry. | Homo sapiens | 242 | subcellular format | Kuster lab chemical proteomics drug profiling | ||
7. | ALA4025049 | B | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
8. | ALA4043860 | B | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
9. | ALA4054987 | B | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control | Homo sapiens | 2 | assay format | Scientific Literature | ||
10. | ALA4118325 | B | Inhibition of CHED in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKCSNILLNNR probe by mass-spectrometric analysis relative to control | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
11. | ALA4156939 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
12. | ALA4185718 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
13. | ALA4230618 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
14. | ALA4264207 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
15. | ALA4307723 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
16. | ALA4333314 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
17. | ALA4357796 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
18. | ALA4365641 | B | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
19. | ALA4382427 | B | Binding affinity to wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature | ||
20. | ALA4389146 | B | Inhibition of wild-type human partial length CDC2L5 (H675 to S1054 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control | Homo sapiens | 1 | assay format | Scientific Literature |